A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients
Background & Aims: Retrospective cross-sectional studies linked sarcopenia and myosteatosis with metabolic dysfunction-associated fatty liver disease (MAFLD). Here, we wanted to clarify the dynamic relationship between sarcopenia, myosteatosis, and MAFLD. Methods: A cohort of 48 obese patien...
Main Authors: | Maxime Nachit, Nicolas Lanthier, Julie Rodriguez, Audrey M. Neyrinck, Patrice D. Cani, Laure B. Bindels, Sophie Hiel, Barbara D. Pachikian, Pierre Trefois, Jean-Paul Thissen, Nathalie M. Delzenne |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555921000999 |
Similar Items
-
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021-02-01) -
Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01) -
Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
by: Raila Aro, et al.
Published: (2022-05-01) -
Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
by: Min-Kyu Kang, et al.
Published: (2022-09-01) -
Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors
by: Mengchen Liu, et al.
Published: (2024-04-01)